536 related articles for article (PubMed ID: 1908882)
1. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
Kabat EA; Wu TT
J Immunol; 1991 Sep; 147(5):1709-19. PubMed ID: 1908882
[TBL] [Abstract][Full Text] [Related]
2. Sequences of the VH and VL regions of murine monoclonal antibodies against 3-fucosyllactosamine.
Kimura H; Cook R; Meek K; Umeda M; Ball E; Capra JD; Marcus DM
J Immunol; 1988 Feb; 140(4):1212-7. PubMed ID: 2893825
[TBL] [Abstract][Full Text] [Related]
3. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
4. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
5. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
[TBL] [Abstract][Full Text] [Related]
6. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
7. A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity.
Hudson NW; Bruccoleri RE; Steinrauf LK; Hamilton JA; Mudgett-Hunter M; Margolies MN
J Immunol; 1990 Oct; 145(8):2718-24. PubMed ID: 2120338
[TBL] [Abstract][Full Text] [Related]
8. VH and VL gene usage by murine IgG antibodies that bind autologous insulin.
Ewulonu UK; Nell LJ; Thomas JW
J Immunol; 1990 Apr; 144(8):3091-8. PubMed ID: 2109009
[TBL] [Abstract][Full Text] [Related]
9. [Genetic bases of antibody diversity].
Baranov OK; Eppel' MS
Genetika; 1984 Sep; 20(9):1397-413. PubMed ID: 6437904
[TBL] [Abstract][Full Text] [Related]
10. The immune response toward beta-adrenergic ligands and their receptors. VIII. Extensive diversity of VH and VL genes encoding anti-alprenolol antibodies.
Nahmias C; Strosberg AD; Emorine LJ
J Immunol; 1988 Feb; 140(4):1304-11. PubMed ID: 3125254
[TBL] [Abstract][Full Text] [Related]
11. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
[TBL] [Abstract][Full Text] [Related]
12. Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context.
Khalifa MB; Weidenhaupt M; Choulier L; Chatellier J; Rauffer-Bruyère N; Altschuh D; Vernet T
J Mol Recognit; 2000; 13(3):127-39. PubMed ID: 10867708
[TBL] [Abstract][Full Text] [Related]
13. The specificity properties that distinguish members of a set of homologous anti-digoxin antibodies are controlled by H chain mutations.
Near RI; Bruccoleri R; Novotny J; Hudson NW; White A; Mudgett-Hunter M
J Immunol; 1991 Jan; 146(2):627-33. PubMed ID: 1898959
[TBL] [Abstract][Full Text] [Related]
14. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
[TBL] [Abstract][Full Text] [Related]
15. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
Riechmann L
J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of anti-idiotypic monoclonal antibodies in the HLA-DR antigenic system.
Armandola EA; Mariani SM; Zwickl M; Hardman N; Ferrone S
Eur J Immunol; 1992 Nov; 22(11):2893-9. PubMed ID: 1425914
[TBL] [Abstract][Full Text] [Related]
17. Cardiolipin binding a light chain from lupus-prone mice.
Pereira B; Benedict CR; Le A; Shapiro SS; Thiagarajan P
Biochemistry; 1998 Feb; 37(5):1430-7. PubMed ID: 9477972
[TBL] [Abstract][Full Text] [Related]
18. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
Polymenis M; Stollar BD
J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893
[TBL] [Abstract][Full Text] [Related]
19. Restricted usage of VH and V kappa genes by murine monoclonal antibodies against 3-fucosyllactosamine.
Kimura H; Buescher ES; Ball ED; Marcus DM
Eur J Immunol; 1989 Sep; 19(9):1741-6. PubMed ID: 2571506
[TBL] [Abstract][Full Text] [Related]
20. Role of mouse VH10 and VL gene segments in the specific binding of antibody to Z-DNA, analyzed with recombinant single chain Fv molecules.
Brigido MM; Polymenis M; Stollar BD
J Immunol; 1993 Jan; 150(2):469-79. PubMed ID: 8419479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
